Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Allergic Asthma”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07120503
What this trial is testing

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

Who this might be right for
Asthma (Diagnosis)
Windward Bio 136
Early research (Phase 1)Study completedNCT00386178
What this trial is testing

Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma

Who this might be right for
Asthma
University of North Carolina, Chapel Hill 16
Large-scale testing (Phase 3)Study completedNCT01202903
What this trial is testing

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 616
Testing effectiveness (Phase 2)Study completedNCT03299686
What this trial is testing

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 118
Large-scale testing (Phase 3)Study completedNCT06920771
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Who this might be right for
House Dust Mite AllergyHouse Dust Mite Rhinitis
HAL Allergy 691
Testing effectiveness (Phase 2)Ended earlyNCT01673672
What this trial is testing

CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma

Who this might be right for
Moderate to Severe Allergic Asthma
Cytos Biotechnology AG 365
Large-scale testing (Phase 3)Study completedNCT00599027
What this trial is testing

An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma

Who this might be right for
Allergic RhinitisAsthma
Organon and Co 51
Post-approval studies (Phase 4)Study completedNCT00670930
What this trial is testing

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

Who this might be right for
Allergic Asthma
Novartis Pharmaceuticals 36
Post-approval studies (Phase 4)Study completedNCT00139152
What this trial is testing

Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair

Who this might be right for
Lung Disease
Creighton University 65
Large-scale testing (Phase 3)Study completedNCT00482508
What this trial is testing

Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients

Who this might be right for
Asthma
Novartis 95
Testing effectiveness (Phase 2)Study completedNCT01437735
What this trial is testing

Dose Finding Study for QAW039 in Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 1,043
Not applicableWithdrawnNCT01144910
What this trial is testing

The Long-term Prognosis of Moderate to Severe Bronchial Hyperresponsiveness (BHR) in Asthmatic Preschool Children

Who this might be right for
Intrinsic AsthmaAllergic AsthmaAllergy+1 more
Johann Wolfgang Goethe University Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT07342803
What this trial is testing

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

Who this might be right for
Allergic Asthma
Longbio Pharma 200
Post-approval studies (Phase 4)Ended earlyNCT04195958
What this trial is testing

Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Who this might be right for
Moderate-to-severe Allergic Asthma
Genentech, Inc. 3
Large-scale testing (Phase 3)Study completedNCT05813470
What this trial is testing

Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma

Who this might be right for
Allergic AsthmaUncontrolled Moderate to Severe
Cinnagen 256
Not applicableUnknownNCT06771934
What this trial is testing

Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma

Who this might be right for
Allergic Asthma
Qianfoshan Hospital 60
Post-approval studies (Phase 4)Study completedNCT00283504
What this trial is testing

A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy

Who this might be right for
ALLERGIC ASTHMA
Children's Hospital of The King's Daughters 13
Testing effectiveness (Phase 2)Looking for participantsNCT05008965
What this trial is testing

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

Who this might be right for
Allergic Asthma
Oneness Biotech Co., Ltd. 100
Large-scale testing (Phase 3)Study completedNCT04607629
What this trial is testing

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma

Who this might be right for
Bronchial Asthma
AO GENERIUM 192
Not applicableUnknownNCT01776177
What this trial is testing

The REALITY Study - a Real-life Long-term Analysis of Xolair Therapy

Who this might be right for
Allergic Asthma
Joseph D. Diaz, MD 240
Next Page